Recent Finacing
Recent Raise
Aethon Therapeutics is a company developing antibody-based cancer therapeutics that leverage small-molecule covalent inhibitors to create peptide-drug conjugates or beacons.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Aethon Therapeutics.